Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marta Torres-Narbona

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
International Journal of Antimicrobial Agents|December 17, 2008
Treatment of invasive fungal infections in immunocompromised and transplant patients: AmBiLoad trial and other new dataPatricia Muñoz, Jesus Guinea, Marta Torres Narbona, et al.
Antimicrobial Agents and Chemotherapy|July 9, 2008
Clinical isolates of Aspergillus species remain fully susceptible to voriconazole in the post-voriconazole eraJesús Guinea, Sandra Recio, Teresa Peláez, et al.
Antimicrobial Agents and Chemotherapy|January 24, 2008
In vitro antifungal activities of isavuconazole (BAL4815), voriconazole, and fluconazole against 1,007 isolates of zygomycete, Candida, Aspergillus, Fusarium, and Scedosporium speciesJesús Guinea, Teresa Peláez, Sandra Recio, et al.
Antimicrobial Agents and Chemotherapy|December 30, 2006
In vitro activities of amphotericin B, caspofungin, itraconazole, posaconazole, and voriconazole against 45 clinical isolates of zygomycetes: comparison of CLSI M38-A, Sensititre YeastOne, and the EtestMarta Torres-Narbona, Jesús Guinea, José Martínez-Alarcón, et al.
The Journal of Infection|November 26, 2009
Post-surgical invasive aspergillosis: an uncommon and under-appreciated entityJulia Jensen, Jesús Guinea, Marta Torres-Narbona, et al.
Journal of Clinical Microbiology|March 30, 2007
Impact of zygomycosis on microbiology workload: a survey study in SpainMarta Torres-Narbona, Jesús Guinea, José Martínez-Alarcón, et al.
Medical Mycology|March 20, 2010
Antifungal susceptibility, serotyping, and genotyping of clinical Cryptococcus neoformans isolates collected during 18 years in a single institution in Madrid, SpainJesús Guinea, Ferry Hagen, Teresa Peláez, et al.
Medical Mycology|October 31, 2008
Empirical treatment of candidemia in intensive care units: fluconazole or broad-spectrum antifungal agents?Jesús Guinea, Teresa Peláez, Marta Rodríguez-Créixems, et al.
Journal of Clinical Microbiology|April 16, 2010
Rapid antifungal susceptibility determination for yeast isolates by use of Etest performed directly on blood samples from patients with fungemiaJesús Guinea, Sandra Recio, Pilar Escribano, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
International Journal of Antimicrobial Agents|December 17, 2008
Treatment of invasive fungal infections in immunocompromised and transplant patients: AmBiLoad trial and other new dataPatricia Muñoz, Jesus Guinea, Marta Torres Narbona, et al.
Antimicrobial Agents and Chemotherapy|July 9, 2008
Clinical isolates of Aspergillus species remain fully susceptible to voriconazole in the post-voriconazole eraJesús Guinea, Sandra Recio, Teresa Peláez, et al.
Antimicrobial Agents and Chemotherapy|January 24, 2008
In vitro antifungal activities of isavuconazole (BAL4815), voriconazole, and fluconazole against 1,007 isolates of zygomycete, Candida, Aspergillus, Fusarium, and Scedosporium speciesJesús Guinea, Teresa Peláez, Sandra Recio, et al.
Antimicrobial Agents and Chemotherapy|December 30, 2006
In vitro activities of amphotericin B, caspofungin, itraconazole, posaconazole, and voriconazole against 45 clinical isolates of zygomycetes: comparison of CLSI M38-A, Sensititre YeastOne, and the EtestMarta Torres-Narbona, Jesús Guinea, José Martínez-Alarcón, et al.
The Journal of Infection|November 26, 2009
Post-surgical invasive aspergillosis: an uncommon and under-appreciated entityJulia Jensen, Jesús Guinea, Marta Torres-Narbona, et al.
Journal of Clinical Microbiology|March 30, 2007
Impact of zygomycosis on microbiology workload: a survey study in SpainMarta Torres-Narbona, Jesús Guinea, José Martínez-Alarcón, et al.
Medical Mycology|March 20, 2010
Antifungal susceptibility, serotyping, and genotyping of clinical Cryptococcus neoformans isolates collected during 18 years in a single institution in Madrid, SpainJesús Guinea, Ferry Hagen, Teresa Peláez, et al.
Medical Mycology|October 31, 2008
Empirical treatment of candidemia in intensive care units: fluconazole or broad-spectrum antifungal agents?Jesús Guinea, Teresa Peláez, Marta Rodríguez-Créixems, et al.
Journal of Clinical Microbiology|April 16, 2010
Rapid antifungal susceptibility determination for yeast isolates by use of Etest performed directly on blood samples from patients with fungemiaJesús Guinea, Sandra Recio, Pilar Escribano, et al.
Pageof 1